Market Overview:
The global medical molecular imaging market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of cancer, growing geriatric population, and technological advancements in medical molecular imaging devices. Oncology is the largest application segment of the global medical molecular imaging market and is expected to grow at a CAGR of 7.8% from 2018 to 2030. This can be attributed to the increasing incidence of cancer and rising demand for early diagnosis and treatment options for cancer patients. Cardio and vascular application segment is expected to grow at a CAGR of 7.7% from 2018-2030 due high prevalence rate cardiovascular diseases (CVDs) across globe . Neurology application segment is also anticipated witness highest growth during forecast period owing increase in number neurological disorders cases coupled with technological advancement that offers better image quality for accurate diagnosis . Regionally, North America dominates global medical molecular imaging market followed by Europe due high adoption rate technology driven devices , reimbursement scenario favorable for diagnostic procedures , presence key players etc . Asia Pacific region projected exhibit highest growth during forecast period owing increase disposable income people along with growing awareness about benefits associated with use these devices .
Product Definition:
Medical Molecular Imaging is the study of images created by exposing tissues or organs to radiation. These images can be used to diagnose and treat medical conditions.
MRI:
Magnetic Resonance Imaging (MRI) is a diagnostic medical procedure used to detect diseases or damage in the body. It uses magnetic fields and radio waves to produce images of organs, tissues, and bones. MRI works by detecting changes in the blood oxygen level while the patient is exposed to a high magnetic field inside the closed chamber.
CT:
CT or computed tomography is a diagnostic imaging technique that involves the use of X-rays to obtain detailed images of targeted areas. CT scan works by scanning the area to be examined multiple times in quick succession and then analyzing the data obtained from these scans. The major advantage of this technique is that it can provide 3D images, even for objects which are far off as compared to other conventional imaging techniques such as MRI and ultrasound.
Application Insights:
On the basis of application, the global medical molecular imaging market is segmented into oncology, cardiology and vascular, neurology, and other applications. The oncology segment dominated the overall market in terms of revenue share in 2017. This can be attributed to factors such as an increase in cancer prevalence coupled with rising awareness about early diagnosis. According to WHO¢â‚¬â„¢s estimates, around 1 billion people worldwide are diagnosed with cancer every year and it is estimated that around 1 million people die due to this disease every year globally.
The cardiology & vascular segment is expected to grow at a lucrative rate over the forecast period owing to factors such as increasing incidence rates of cardiovascular diseases (CVDs) coupled with rising geriatric population across countries such as India and China who require advanced healthcare services along with growing demand for diagnostic solutions for CVDs from both patients as well as insurance companies.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high adoption rate of advanced technologies and well-established healthcare infrastructure. Moreover, increasing government funding for R&D activities pertaining to molecular imaging is also expected to contribute toward regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising medical tourism and improving healthcare infrastructure in emerging countries such as India and China. In addition, growing target population base due to increased immigration from developed economies is further expected boost regional demand during the forecast period. Japan has one of the highest per capita spending on healthcare worldwide; hence making it a lucrative market for international players operating in this space (Saunders et al., 2016).
Growth Factors:
- Increasing demand for minimally invasive surgeries: The global medical molecular imaging market is expected to grow at a CAGR of 9.5% during the forecast period due to the increasing demand for minimally invasive surgeries. This is because of the advantages offered by medical molecular imaging over traditional diagnostic techniques such as X-rays and CT scans.
- Rising prevalence of cancer: The rising prevalence of cancer is another major growth driver for the global medical molecular imaging market. Cancer is one of the leading causes of death worldwide, and this number is only expected to increase in future due to factors such as aging population and lifestyle changes. Medical molecular imaging offers an early diagnosis and treatment options for various types of cancers, which is driving its adoption worldwide.
- Growing use of PET scanners: PET scanners are considered as one of the most advanced types of medical molecular Imaging devices available today, owing to their ability to image both anatomical structure and function simultaneously in a single scan session.. This has led to their growing use in hospitals across the world, thereby propelling growth prospects for this segment during the forecast period .
Scope Of The Report
Report Attributes
Report Details
Report Title
Medical Molecular Imaging Market Research Report
By Type
MRI, CT, PET, SPECT, Ultrasound
By Application
Oncology, Cardio and Vascular, Neurology, Others
By Companies
Cardiarc, Digirad, Gamma Medica, GE, Gvi Medical Devices, Hitachi, Mediso, CMR Naviscan, Neurologica, Neusoft, BC Technical, Philips, Positron, Siemens, Biosensors International, Toshiba, Trivitron Healthcare, Molecular Devices
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
187
Number of Tables & Figures
131
Customization Available
Yes, the report can be customized as per your need.
Global Medical Molecular Imaging Market Report Segments:
The global Medical Molecular Imaging market is segmented on the basis of:
Types
MRI, CT, PET, SPECT, Ultrasound
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oncology, Cardio and Vascular, Neurology, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Cardiarc
- Digirad
- Gamma Medica
- GE
- Gvi Medical Devices
- Hitachi
- Mediso
- CMR Naviscan
- Neurologica
- Neusoft
- BC Technical
- Philips
- Positron
- Siemens
- Biosensors International
- Toshiba
- Trivitron Healthcare
- Molecular Devices
Highlights of The Medical Molecular Imaging Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- MRI
- CT
- PET
- SPECT
- Ultrasound
- By Application:
- Oncology
- Cardio and Vascular
- Neurology
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Medical Molecular Imaging Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Medical Molecular Imaging is a type of imaging that uses medical-grade radiation to create images of molecules inside the body. This technology can be used to diagnose and treat diseases, and is often used in conjunction with other forms of imaging such as CT scans or MRI scans.
Some of the major players in the medical molecular imaging market are Cardiarc, Digirad, Gamma Medica, GE, Gvi Medical Devices, Hitachi, Mediso, CMR Naviscan, Neurologica, Neusoft, BC Technical, Philips, Positron, Siemens, Biosensors International, Toshiba, Trivitron Healthcare, Molecular Devices.
The medical molecular imaging market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Medical Molecular Imaging Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Medical Molecular Imaging Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Medical Molecular Imaging Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Medical Molecular Imaging Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Medical Molecular Imaging Market Size & Forecast, 2020-2028
4.5.1 Medical Molecular Imaging Market Size and Y-o-Y Growth
4.5.2 Medical Molecular Imaging Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 MRI
5.2.2 CT
5.2.3 PET
5.2.4 SPECT
5.2.5 Ultrasound
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Oncology
6.2.2 Cardio and Vascular
6.2.3 Neurology
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Medical Molecular Imaging Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Medical Molecular Imaging Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 MRI
9.6.2 CT
9.6.3 PET
9.6.4 SPECT
9.6.5 Ultrasound
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Oncology
9.10.2 Cardio and Vascular
9.10.3 Neurology
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 MRI
10.6.2 CT
10.6.3 PET
10.6.4 SPECT
10.6.5 Ultrasound
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Oncology
10.10.2 Cardio and Vascular
10.10.3 Neurology
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 MRI
11.6.2 CT
11.6.3 PET
11.6.4 SPECT
11.6.5 Ultrasound
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Oncology
11.10.2 Cardio and Vascular
11.10.3 Neurology
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 MRI
12.6.2 CT
12.6.3 PET
12.6.4 SPECT
12.6.5 Ultrasound
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Oncology
12.10.2 Cardio and Vascular
12.10.3 Neurology
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 MRI
13.6.2 CT
13.6.3 PET
13.6.4 SPECT
13.6.5 Ultrasound
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Oncology
13.10.2 Cardio and Vascular
13.10.3 Neurology
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Medical Molecular Imaging Market: Competitive Dashboard
14.2 Global Medical Molecular Imaging Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Cardiarc
14.3.2 Digirad
14.3.3 Gamma Medica
14.3.4 GE
14.3.5 Gvi Medical Devices
14.3.6 Hitachi
14.3.7 Mediso
14.3.8 CMR Naviscan
14.3.9 Neurologica
14.3.10 Neusoft
14.3.11 BC Technical
14.3.12 Philips
14.3.13 Positron
14.3.14 Siemens
14.3.15 Biosensors International
14.3.16 Toshiba
14.3.17 Trivitron Healthcare
14.3.18 Molecular Devices
